A peptide associated with antiviral activity, isolated from the high plant Melia azedarach L. was purified and partially characterized. Crude extracts of green leaf were purified by gel filtrationpn Sephadex G-100 followed by DEAE-Sephadex A~g~. After column chromatography purification, an aciive compound II was revealed by elution with chloroform: methanol (95:5). Further analysis using thin-layer chromatography (TLC) revealed three components. With Rf 0.37 (component II), one of these had the highest antiviral activity as determined by inhibition of VSV replication.
Introduction
A search for antiviral activity in high plants traditionally used in folk medicine revealed that crude extracts of Melia azedarach L. leaves inhibited the replication of DNA and RNA viruses in cell cultures (Wachsman et st., 1982 , Andrei et el., 1986 . In addition, crude extract administration to suckling mice infected with the arenavirus Tacaribe protected them against encephalitis (Coulombie et el., 1992; Andrei et el., 1985) . Further studies performed with partially purified M. azedarach L. leaf extracts, indicated that the inhibitor, designated meliacine (Andrei et et., 1990) , induced an antiviral state in a large variety of continuous and primary cell cultures (Andrei et el., 1988) . The refractory state against viral infection was not related to the interferon system. On the contrary, interferon production was depressed greatly in meliacine treated L-929 cells and primary mouse embryo fibroblast cultures (Andrei et el., 1990) .
Studies on the action of meliacine in the infection of BHK 21 cells by Sindbis virus showed that viral adsorption or penetration was not affected. However viral RNA and protein synthesis were inhibited totally in cells pretreated with meliacine for 2 h before infection (Wachsman et al., 1988) .
Due to these interesting activities of meliacine and the fact that important human pathogens, for example, HSV1 and HSV2 are susceptible to this compound (Wachsman et al., 1982) , a search for a method of purification was undertaken in order to start a structural study to unravel its chemical nature.
Results

Purification
Previous results obtained with partially purified meliacine suggested that the biological activity was associated with a polypeptide, since the activity was abolished by trypsin treatment (Wachsman et sl., 1984) . However, the recovery of the antiviral activity was low when active extracts were subjected to the usual methods of purification such as precipitation with ammonium sulphate,polyethylene glycol, 2 volumes of ethanol or 10% triclhoroacetic acid. Therefore, other methods were explored to purify the active principle.
A Iyophilysed crude extract, resuspended in 10 mM potassium phosphate buffer was chromatographed in Sephadex G-100. Antiviral activity was determined by the ratio between VSV titre in cell cultures treated with the subsequent fractions of the column vs. VSV titre in mock treated cells. Results (Fig. 1) show that the antiviral factor (meliacine) is a low MW component which was separated from non-active contaminating material which was excluded. For further purification antiviral fractions (10-14) were pooled, Iyophilysed and chromatographed on DEAE-Sephadex A-25 ( Fig. 2) . Meliacine was not retained on the resin but further elution with KCI of increasing molarity showed that many contaminating proteins were separated by this procedure.
In order to design further purification steps, DEAE fraction was then treated with different solvents to determine its range of solUbility. Results quoted in Table 1 show that meliacine remained insoluble in ether or chloroform and was fully solubilized in water or alcohol. Since meliacine was of low molecular weight and soluble in solvents of high or medium polarity, a column chromatography purification on silica gel was tried. Elution with different ratios of chloroform:methanol showed that most of the activity was recovered with the chloroform : methanol 95:5 mixture (Table 2 ). When this fraction was analysed by thinlayer chromatography (TLC) three components with Rf 0.46 (I), 0.37 (II), and 0.28 (III) respectively. were 
Structural studies
The amino acid content of meliacine (compound II) estimated by the nynhidrine method was 86-87% while a carbohydrate content of 13% was found by the phenol-sulphuric acid method. Analysis by paper chromatography detected. Component lI(meliacine), eluted from the plate, was the only component which retained antiviral activity (Table 3) , although almost 50% of the initial activity was lost. Using further HPLC analysis (not shown) purified meliacine appeared to be homogeneous and displayed a range of antiviral activity (Table 4 ) similar to crude extract (Wachsman et el., 1982) .
The purification procedure applied to M. azedarach crude extract increased 20-fold the specific antiviral activity tested against VSV with concomitant loss of cytotoxicity (Andrei et el., 1985) . Only 2-3 % of the total initial antiviral activity was recovered.
DE 5 0 is the reciprocal of the dilution of the assayed fraction which reduced VSV CPE by 50%. a Total DE 5 0 after considering the volume of each fraction (ml). dence with the included volume of the column (Fig. 3 ). Furthermore, paper chromatography of this included peak, showed the presence of a single spot coincident with glucose. When the mild alkaline degradation was performed under reducing conditions, sorbitol was detected as the acetylated derivative by gas liquid chromatography (GLC).
The percentage of neutral sugars determined by the phenol sulphuric acid method indicated that only one or two glucose units were present in meliacine.
. . . .
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(;p\ DE so was calculated as explained in Table 2 . Table 3 . Antiviral activity of components obtained after TLC of the chloroform:methanol (95:5) silicagel column fraction and gas liquid chromatography of an acid hydrolysate showed glucose to be the only sugar component (not shown). Non-aromatic amino acids were found by amino acid analysis (Table 5 ). According to the molar composition obtained, a MW of 2200-2300 was estimated. This MW is in accordance with the large inclusion volume obtained by gel filtration (Fig.1) . When the N-terminal amino acid was searched for no dansyl derivative was obtained suggesting a cyclic structure. In order to confirm this posibility, a sample of purified meliacine was hydrolysed with carqjkipeptidase A. Automatic amino acid analysis showeQl'that the enzyme was not effective. Taken together with the solubility properties; these data supported a cyclic structure for meliacine.
The linkage of the monosaccharide unit to the peptide moiety was investigated by means of an alkaline degradation. While purified meliacine was excluded from a Sephadex G-10 column, conditions used to release 0glycosidic chains showed only one sugar peak in coinci- Crude or partially purified fresh leaf extracts of Melia azedarach L. display various biological activities, mainly, as antiviral and immune modulators. Before now it has not been shown whether only one chemical compound is responsible for the different activities observed or whether there are more.
Virus
Discussion
a Pre-treatment: vero cells grown in 96-well plastic plates were incubated with serial dilutions of meliacine (5 mg ml-') for 2 h at 3rC. Then, media were removed and the cells infected with approximately 1000 p.f.u. of virus, using a plate for each virus assayed. After virus adsorption at 3rC for 1 h, fresh medium was added and maintained up to the end of the experiment. For VSV, PrV, HSV1, HSV2 and Sindbis virus the CPE was recorded at 24 h post infection. For Junin and Tacaribe virus, CPE was recorded at 72 h post infection. Experiments with Sindbis virus were performed in BHK21 cells.
b Post-treatment: cells grown in 96-well plastic plates were infected with 1000 p.f.u. of each virus. After 1 h incubation at 37°C and to allow virus adsorption, fresh medium containing serial dilutions of meliacine were added and maintained up to the end of the experiment as explained in a. Control uninfected mock treated cells were run in each plate. Ci so is the concentration of rneliacine which inhibits virus CPE by 50%. Cytotoxic activity: CC so > 0.5~g mr", The results reported here indicate that a cyclic peptide present in Melia azedarach extracts is responsible for the antiviral activity found against members of DNA and RNA virus families (Table 4 ) which share the characteristic of being enveloped. As the crude extract, meliacine affected slightly the replication of RNA in enveloped viruses (Wachsman et et., 1982) and was able to produce a state refractory to virus infection in a variety of cells.
The purification method described here, allowed isolation of the antiviral compound present in leaf extracts. However, the low amount of pure compound obtained, precluded the investigation of the immunomodulatory activity (Andrei et sl., 1990; Benencia et et., 1992) .
A remarkable property of meliacine is its lack of demonstrable cytotoxicity, indicating that during the purification procedure toxic compounds are eliminated. Several cyclic peptides with biological activity have been reported (Botes et et., 1984; Hanschumacher et el., 1984; Merker et sl., 1984; Potgieter et sl., 1989) . The most studied, cyclosporine A, a peptide metabolite from Trichoderma polysporum with immunosuppressive actvity, shows similar solubility in organic solvents as meliacine and could be partially purified by silica gel chromatography (Ruegger et sl., 1976) .
The presence of one or two single glucose units is an unusual feature of meliacine peptide. Release of the sugar by mild alkali indicated an Q-glycosidic linkage. There is no report on this type of attachment to peptides. Although common Q-glycosidic chains are joined through man nose, xylose or N-acetylgalactosamine to serine or threonine, in the last years some novel protein saccharides linkages have been reported (Abeijon et el., 1988) .
Single N-acetylglucosamine residues in Q-Iinkages to protein were reported in rat liver subcellular organelles. O-Glycosylation proceeds directly from the nucleotide sugar to the polypeptide, without any phosphate lipid intermediate (Hanover et el., 1980) . This biosynthetic route can give rise to a wide variety of structures.
It was shown previously that the antiviral activity of meliacine decays abruptly at a pH above 9 (unpublished results). Further studies are necessary to determine whether the loss of activity is due only to the release of glucose or more probably to a concomitant change on the peptide conformation.
Materials and Experimental procedures
Cells
Vero cells (derived from African green monkey kidney) were grown in Eagle's minimum essential medium (MEM) supplemented with 5% inactivated calf serum and 50 Jlgmr" gentamycin. BHK-21 cells were grown in Dulbecco's modified MEM supplemented with 8% calf serum and antibiotics. Confluent 48 hold monolayers were used in all the experiments.
Maintenance medium consisted of Eagle's basal medium (BME) containing 2-3% calf serum and gentamycin. BHK cells (baby hamster kidney) were maintained in Dulbecco's medium supplementedwith 8% calf serum and antibiotics.
Plant material
Melia azedarach L. fresh green leaves collected during late Spring, Summer and early Autumm were used as source of meliacine. The specimens harvested from trees grown in Buenos Aires City were identified and checked at the Department of Botany Science School, Buenos Aires University, where a specimen was kept and registered as BAFC 1432 (Argentina).After the leaveswere removedfrom the trees, they were washed immediately with distilled water and stored at -20°C until processed.
Viruses VSV (Indiana strain); Junin virus (XJ CI3 strain); Tacaribe virus (TRLV 11573 strain); HSV 1 (Mc Intire strain); HSV 2 (provided by Malbran Institute, Argentina); Pseudorabies viruses (PrV) was a strain isolated fron field from an infected pig) and Sindbis virus (prototypestrain) were used. All viruses were propagated in Vero cells except for Sindbis virus which was grown in BHK cells.
Preparation of the plant extract
The thawed leaves were cut into small pieces and extracted in a Waring blender with an equal weight of 10 mM potassium phosphate buffer, pH 7.2 containing 0.35 M KCI. The sap obtained was pressed through a cheese cloth and was centrifuged at 10000 9 for 1 h. Pellets were discarded and the supernatants Iyophilysed. All operations were carried out at 4°C.
Chromatographic methods
Sephadex G-100 and G-50 columns and G-10 (Pharmacia LKB, Uppsala, Sweden) (50 x 1 ern, 100-200 mesh) were used with sodium phosphate buffer pH7.2 as eluent. Fractions of 1 ml were collected. Ion exchange chromatography was performed on DEAE-SephadexA-25 (25 ml) and eluted first with 2 volumes of the same buffer and further with a KCI gradient in buffer phosphate pH 7.2 (from 0.25 to 0.5 M). Fractions of 3 ml were collected.
Proteins were detected at 280 nm, by Lowry's method (Lowry et el., 1951) or by ninhydrine (Spies, 1957) . Carbohydrates were analysed by the phenol-sulphuric acid method (DUbois et el., 1956) . Bovine albumine (75 kDa), ovoalbumine (43 kDa), and insuline (3.1 kDa) (Sigma Chemical Co., St Louis) were used as molecular weight markers. Silica gel 60 (230-400 mesh) E (Merck, Darmstadt,Germany) column chromatography was performed with increasing concentrations of methanol in chloroform. Thin layer chromatography (TLC) was performed on plastic sheets precoated with silica gel 60 F (E. Merck) with chloroform : methanol (9:1 v/v). Detection was effected by spraying the plates with 5% sulphuric acid in' ethanol with subsequent heating. Paper chromatography was performed on Whatman Number 1 paper with butanol: pyridine: water (6:4:3 v/v) as solvent. Detection was effected with silver nitrate-sodium hydroxide (Trevelyan et al., 1950) . Gas liquid chromatography was performed with a Hewlett-packard 5830 A gas chromatograph equipped with glass columns packed with 3% ECNSS-M on gas chrom Q (100-200 mesh), nitrogen 24 ml mln", Ti 210°C ; Td 210°C ; Tc 190"C. S4gars were analysed as alditol acetates. High performance liquid chromatography was performed with a Micromeritics liquid chromatograph equipped with an ultraviolet variable detector and a Rheodyne lnyector using a Lichrosorb silica 60 (10 mm) column (200 x4.6 mm) eluted with hexane: isopropanol (70:30 v/v) at a flow rate of 1 ml rnin".
Acid hydrolysis
Samples were hydrolysed with 2 N HCI at 100°C for 3 h under nitrogen. Acid removal was accomplished by evaporation at 30°C under diminished pressure with repeated addition of water. The hydrolysate was passed through a Dowex 50 W (H+) column. Neutral sugars were eluted with water and peptides were eluted with 1N HCI. The acid fraction was freezedried and further hydrolysed with 6 NHCLfit 100-1 05°C for 24 h under nitrogen. Hydrolysates were fr~~from acid and analysed in a Beckman 119 CL authomatilt'analyser equipped with a Beckman W3 resin (6 x 220 em).
Alkaline degradation
The purified compound was dissolved in 1 ml of 0.1 M NaOH and kept 22 h at 30°C. The sample was treated with acetic acid up to pH 5 evaporated to dryness and subjected to column chromatography.
In another experiment, the alkaline treatment was performed in the presence of 0.1 M NaBH 4 . Carboxyl-terminal amino-acid analysis: C-terminal amino acid was analysed by digestion with carboxipeptidase A (Richardson et al., 1984) . Amino-terminal aminoacid analysis: N-terminal aminoacid was analysed by the dansyl chloride method. (Gray, 1972.) 
Solubility test
The active material obtained from the DEAE-Sephadex column was Iyophilysed and tested for solubility in different solvents. When part of the material remained insoluble, it was centrifuged and separated. Both fractions were dried, solubilized in water and assayed for activity.
Antiviral activity
Quantification of the antiviral activity was performed as described previously (Andrei et al., 1988) . Vero cell monolayers were pretreated with BME or BME containing the meliacine active factor at 37°C for 2 h. Then the medium was removed and the cultures were washed twice with PBS and infected with VSV at a multiplicity of 1. After incubation at 37°C for 1 h to allow virus adsorption, the inocula were removed. Cells were further incubated with BME alone. Supernatants were harvested at 16-20 h post infection and virus was titrated by A plant antiviral cyclic peptide 109 plaque assay. The ratio between virus titre in meliacine-treated cultures vs. virus titre in untreated (control cells) represents the reduction in virus growth.
Titration of the antiviral factor by cytopathic effect (CPE) reduction
For some comparative purposes or when small amounts of the antiviral factor were available, tritation WaS performed in 96well flat bottom plates (Nunc, Roskilde, Denmark). First, twofold serial dilutions of the antiviral compound in maintenance medium were added to the wells. Immediately after, 2.0 x 10 4 Vero cells were seeded in each well and incubated at 37°C. Following 4 h, to allow cell adherence, media were removed and meliacine-treated wells received 1.0 x 10 3 p.f.u. of VSV and the cultures were further incubated at 37"C. In parallel, cells were treated with serial dilutions of the antiViralfraction or meliacine but were mock infected. After 24h of Incubation, when CPE was recorded, cells were observed for signs of morphological alterations. The reciprocal of the dilution of the antiviral fraction resulting in a 50% inhibition of the cytopathic effect is defined as the DE 50.
Antiviral activity of purified meliacine against several viruses was determined in a similar way (pre-treatment). An initial concentration of meliacine of 5 mg ml" was used. Since previous work showed that some viruses were more sensitive to the inhibitor when it is present during the replication cycle (posttreatment) the inhibitor was added after virus adsorption and remained up to the end of the experiment.
Cytotoxicity
Vero-cell monolayers were incubated with MEM containing appropriate dilutions of meliacine. After 48 h supernatant fluids were discarded and adherent cells were removed by trypsin digestion. The cell suspension was stained with trypan blue and viable cells were counted using a haemacytometer. Results were expressed as the ratio between the number of viable cells in treated cultures and viable cells in the untreated control cultures. The 50% cytotoxic concentration (CC so) was defined as the concentration which caused a 50% reduction in the number of viable cells.
